203 related articles for article (PubMed ID: 25527409)
1. Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
Grover SK; Agarwal S; Gupta S; Wadhwa N; Sharma N
Pathol Oncol Res; 2015 Jul; 21(3):651-7. PubMed ID: 25527409
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
3. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
5. Immunoexpression of estrogen receptor-β and progesterone receptor in prostate adenocarcinoma, does it inhibit neoplastic proliferation and invasion?
Bera KN; Yadav SK; Prakash O; Singh S; Sarin N
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S30-S33. PubMed ID: 32108623
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation.
Muñoz E; Gómez F; Paz JI; Casado I; Silva JM; Corcuera MT; Alonso MJ
Eur J Histochem; 2003; 47(2):123-8. PubMed ID: 12777207
[TBL] [Abstract][Full Text] [Related]
7. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
[TBL] [Abstract][Full Text] [Related]
8. Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma.
Azizan N; Hayati F; Tizen NMS; Farouk WI; Masir N
Investig Clin Urol; 2018 Jul; 59(4):232-237. PubMed ID: 29984337
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia.
Gangkak G; Bhattar R; Mittal A; Yadav SS; Tomar V; Yadav A; Mehta J
Investig Clin Urol; 2017 Mar; 58(2):117-126. PubMed ID: 28261681
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of estrogen receptor-beta expression in prostate cancer.
Horvath LG; Henshall SM; Lee CS; Head DR; Quinn DI; Makela S; Delprado W; Golovsky D; Brenner PC; O'Neill G; Kooner R; Stricker PD; Grygiel JJ; Gustafsson JA; Sutherland RL
Cancer Res; 2001 Jul; 61(14):5331-5. PubMed ID: 11454669
[TBL] [Abstract][Full Text] [Related]
12. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
[TBL] [Abstract][Full Text] [Related]
13. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma].
Yang GS; Chen ZD
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1111-5. PubMed ID: 15498298
[TBL] [Abstract][Full Text] [Related]
15. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
Abdou AG; Aiad HA; Sultan SM
APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of topoisomerase II alpha and Her-2/neu in prostatic carcinoma and benign prostatic hyperplasia.
Hasby EA; Saied EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):158-67. PubMed ID: 20029472
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta expression in human prostate tissue.
Pasquali D; Staibano S; Prezioso D; Franco R; Esposito D; Notaro A; De Rosa G; Bellastella A; Sinisi AA
Mol Cell Endocrinol; 2001 Jun; 178(1-2):47-50. PubMed ID: 11403893
[TBL] [Abstract][Full Text] [Related]
18. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
19. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.
Tsurusaki T; Aoki D; Kanetake H; Inoue S; Muramatsu M; Hishikawa Y; Koji T
J Clin Endocrinol Metab; 2003 Mar; 88(3):1333-40. PubMed ID: 12629127
[TBL] [Abstract][Full Text] [Related]
20. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
